This website isn’t supported by Internet Explorer. We recommend that you use a different browser (e.g. Edge, Chrome, Firefox, Safari, or similar) for the best experience of our content.
Novo Nordisk Australia

Novo Nordisk Australia
At Novo Nordisk, we are pleased to offer a range of resources around GLP-1 RA for patients with Type 2 diabetes*:

- Unbranded education on the GLP-1 RA therapeutic class
- Support in the assessment of which patients may be suitable for a GLP-1 RA
- Tools for both prescribers and patients, to assist the initiation of Novo Nordisk’s GLP-1 RA
* All support/information provided in response to this request will be provided by a Novo Nordisk representative and may reference products supplied by Novo Nordisk.

*

*

*

*

*

*

Date of preparation December 2021 | AU21OZM00259